Advertisement
Observational findings over 5+ years of follow-up argue for caution in this population
Investigators urge caution until more data accrue
Zero cases of structural valve deterioration through latest follow-up
Our experts recap the most notable changes and developments
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Database analysis sets stage for a multicenter trial assessing TAVR’s potential role
1,000-patient prospective trial to start enrolling patients soon
PARTNER 2 analysis finds few significant effects
PARTNER 3 and CoreValve Low Risk reveal pros and cons of both approaches
Pathophysiologic understanding and deep experience with BAV are invaluable
Review says there’s too much data variance to know
Advertisement
Advertisement